Researchers have developed a miniature 3D human colon model that mimics lifelike functions to enhance precision in cancer ...

Defining cure in stage II and III colon cancer has been challenging, and has never been systematically studied. In an analysis of 15 randomized trials, colon cancer relapse risk fell to 0.5% by year 6 ...

“ur finding enables the safe discontinuation of follow-up after 6 years, leading to an improvement in quality of life and a reduction in health care system costs,” study researchers wrote.

Dec. 19 -- FRIDAY, Dec. 18 (HealthDay News) -- A family of naturally derived heart drugs called cardiac glycosides shows promise in fighting colon cancer, new research has found. As part of a larger ...

Using a modified natural substance along with current approaches could improve colon cancer treatment, according to findings by University of California, Irvine biologists. The discovery comes from ...

Analysis of 35,213 patients with stage II-III colon cancer revealed that recurrence risk drops below 0.5% at 6 years post-surgery, supporting a practical definition of cure. Women showed a ...

To improve the quality of life of people with cancer, oncologists have regularly recommended exercise. “The thinking in the ...